Harvest Investment Services, LLC Protagonist Therapeutics, Inc Transaction History

Harvest Investment Services, LLC

  • $299 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$18.02 - $29.36 $794,916 - $1.3 Million
44,113 New
44,113 $1.22 Million
Q2 2022

Jul 19, 2022
SELL
$7.06 - $25.52 $94,335 - $340,998
-13,362 Closed
0 $0
Q1 2022

May 03, 2022
SELL
$23.34 - $36.08 $122,885 - $189,961
-5,265 Reduced 28.27%
13,362 $316,000
Q4 2021

Jan 31, 2022
SELL
$17.63 - $37.1 $40,196 - $84,588
-2,280 Reduced 10.91%
18,627 $637,000
Q3 2021

Oct 29, 2021
BUY
$12.95 - $49.69 $270,745 - $1.04 Million
20,907 New
20,907 $370,000

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $1.92B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Harvest Investment Services, LLC Portfolio

Follow Harvest Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Investment Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email